The Journal of the Korean Rheumatism Association 2008; 15(2): 148-152
Published online June 30, 2008
© Korean College of Rheumatology
도주호ㆍ류성열
계명대학교 의과대학 내과학교실
Correspondence to : Ju-Ho Do
A severe adverse reaction to certain drug could be associated with hypersensitivity syndrome, showing the clinical features of infectious mononucleosis including maculopapular rash, fever, lymphadenopathy, leukocytosis, atypical lymphocytes, liver dysfunction, and renal disturbance. We report a systemic lupus erythematosus patient who developed infectious mononucleosis-like syndrome with administration of ceftriaxone/isepamicin for the treatment of pneumonia. This case warrants careful attention to infectious mononucleosis-like syndrome associated with antibiotics administration, especially in febrile patients with known autoimmune diseases such as systemic lupus erythematosus.
Keywords Infectious mononucleosis-like syndrome, Antibiotics, Ceftriaxone, Isepamicin, Systemic lupus erythematosus
The Journal of the Korean Rheumatism Association 2008; 15(2): 148-152
Published online June 30, 2008
Copyright © Korean College of Rheumatology.
도주호ㆍ류성열
계명대학교 의과대학 내과학교실
Ju-Ho Do, Seong-Yeol Ryu
Department of Internal Medicine, Keimyung University School of Medicine, Daegu, Korea
Correspondence to:Ju-Ho Do
A severe adverse reaction to certain drug could be associated with hypersensitivity syndrome, showing the clinical features of infectious mononucleosis including maculopapular rash, fever, lymphadenopathy, leukocytosis, atypical lymphocytes, liver dysfunction, and renal disturbance. We report a systemic lupus erythematosus patient who developed infectious mononucleosis-like syndrome with administration of ceftriaxone/isepamicin for the treatment of pneumonia. This case warrants careful attention to infectious mononucleosis-like syndrome associated with antibiotics administration, especially in febrile patients with known autoimmune diseases such as systemic lupus erythematosus.
Keywords: Infectious mononucleosis-like syndrome, Antibiotics, Ceftriaxone, Isepamicin, Systemic lupus erythematosus
Jae Ho Lee, Il Nam Ju, Hyung Jun Cho, Hong Ki Min, Yeon-Sik Hong
J Rheum Dis 2013; 20(6): 374-377Bong-Woo Lee, M.D., Eui-Jong Kwon, M.D., Ji Hyeon Ju, M.D., Ph.D.
J Rheum Dis -0001; ():So-Young Bang, M.D., Ph.D., Seung Cheol Shim, M.D., Ph.D.
J Rheum Dis 2024; 31(4): 200-211